Superworth

IB Acquisition PE ratio IBAC

Share price divided by earnings per share over the last twelve months, since 2024.

Today, Oct 23, 2026
n/m
losses over the last year
Last meaningful
83.2×
Aug 2026
Peer median
12.8×

IB Acquisition has no meaningful PE ratio today: it lost $0.03 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Aug 2026, at 83.2×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far83.2×29.2×83.2×
202526.1×24.8×44.5×
202444.0×44.0×44.0×

Against its peers

Companies in Healthcare nearest IB Acquisition's size, closest first, today.

CompanyPE ratio
IBACIB Acquisitionn/m
APTAlpha Pro Tech13.6×
ATNMActinium Pharmaceuticals4.2×
SPROSpero Therapeutics10.1×
LFVNLifevantage14.7×
NEPHNephros22.1×
ICCCImmucell128×
KEQUKewaunee Scientific11.9×
PDEXPro DEX15.1×
PLXProtalix BioTherapeutics11.1×
NATRNatures Sunshine Products12.0×
Peer median12.8×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on IB Acquisition

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.